256 related articles for article (PubMed ID: 21822526)
21. Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients.
Kakkar AK; Cohen AT; Tapson VF; Bergmann JF; Goldhaber SZ; Deslandes B; Huang W; Anderson FA;
Ann Surg; 2010 Feb; 251(2):330-8. PubMed ID: 20054273
[TBL] [Abstract][Full Text] [Related]
22. Thromboprophylaxis in ambulatory lung cancer treatment.
Cavaliere L
Clin J Oncol Nurs; 2013 Feb; 17(1):74-9. PubMed ID: 23372099
[TBL] [Abstract][Full Text] [Related]
23. Venous thromboembolism and cancer.
MacLellan DG; Richardson A; Stoodley MA
ANZ J Surg; 2012 May; 82(5):294-8. PubMed ID: 22507393
[TBL] [Abstract][Full Text] [Related]
24. Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients.
Ay C; Pabinger I
Thromb Res; 2012 Apr; 129 Suppl 1():S6-9. PubMed ID: 22682135
[TBL] [Abstract][Full Text] [Related]
25. Approaches to risk-stratifying cancer patients for venous thromboembolism.
Khorana AA; Rao MV
Thromb Res; 2007; 120 Suppl 2():S41-50. PubMed ID: 18023712
[TBL] [Abstract][Full Text] [Related]
26. Risk stratification for cancer-associated venous thromboembolism.
Connolly GC; Khorana AA
Best Pract Res Clin Haematol; 2009 Mar; 22(1):35-47. PubMed ID: 19285271
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and initial treatment of venous thromboembolism in patients with cancer.
Streiff MB
J Clin Oncol; 2009 Oct; 27(29):4889-94. PubMed ID: 19738109
[TBL] [Abstract][Full Text] [Related]
28. Identification of residual risk factors for the development of venous thromboembolism in medical inpatients receiving subcutaneous heparin therapy for prophylaxis.
Kato S; Shimada YJ; Friedmann P; Kashan G; Husk G; Bergmann SR
Coron Artery Dis; 2012 Jun; 23(4):294-7. PubMed ID: 22421548
[TBL] [Abstract][Full Text] [Related]
29. Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines.
Petersen LJ
Cancer Treat Rev; 2009 Dec; 35(8):754-64. PubMed ID: 19762155
[TBL] [Abstract][Full Text] [Related]
30. Cancer and venous thrombosis: current comprehensions and future perspectives.
Lauw MN; van Doormaal FF; Middeldorp S; Buller HR
Semin Thromb Hemost; 2013 Jul; 39(5):507-14. PubMed ID: 23629821
[TBL] [Abstract][Full Text] [Related]
31. Bridging the gap between evidence and practice in venous thromboembolism prophylaxis: the quality improvement process.
Michota FA
J Gen Intern Med; 2007 Dec; 22(12):1762-70. PubMed ID: 17891516
[TBL] [Abstract][Full Text] [Related]
32. Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature.
Tufano A; Guida A; Di Minno MN; Prisco D; Cerbone AM; Di Minno G
Semin Thromb Hemost; 2011 Apr; 37(3):267-74. PubMed ID: 21455860
[TBL] [Abstract][Full Text] [Related]
33. In-hospital symptomatic venous thromboembolism and antithrombotic prophylaxis in Internal Medicine. Findings from a multicenter, prospective study.
Gussoni G; Campanini M; Silingardi M; Scannapieco G; Mazzone A; Magni G; Valerio A; Iori I; Ageno W;
Thromb Haemost; 2009 May; 101(5):893-901. PubMed ID: 19404543
[TBL] [Abstract][Full Text] [Related]
34. Prevention and treatment of deep venous thrombosis.
Ortel TL
Vascular; 2008; 16 Suppl 1():S64-70. PubMed ID: 18544309
[TBL] [Abstract][Full Text] [Related]
35. Management of venous thromboembolism and the potential to impact overall survival in patients with cancer.
Saraiya B; Goodin S
Pharmacotherapy; 2009 Nov; 29(11):1344-56. PubMed ID: 19857150
[TBL] [Abstract][Full Text] [Related]
36. Incidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study.
Scannapieco G; Ageno W; Airoldi A; Bonizzoni E; Campanini M; Gussoni G; Silingardi M; Valerio A; Zilli C; Iori I;
Thromb Haemost; 2010 Oct; 104(4):734-40. PubMed ID: 20664897
[TBL] [Abstract][Full Text] [Related]
37. Risk assessment for cancer-associated thrombosis: what is the best approach?
Khorana AA
Thromb Res; 2012 Apr; 129 Suppl 1():S10-5. PubMed ID: 22682117
[TBL] [Abstract][Full Text] [Related]
38. Venous thromboembolism prevention in patients with heart failure: an often neglected issue.
Imberti D; Pierfranceschi MG; Falciani M; Prisco D
Pathophysiol Haemost Thromb; 2008; 36(2):69-74. PubMed ID: 19127085
[TBL] [Abstract][Full Text] [Related]
39. Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors.
Wun T; White RH
Cancer Invest; 2009; 27 Suppl 1():63-74. PubMed ID: 19291526
[TBL] [Abstract][Full Text] [Related]
40. [Venous thromboembolism prophylaxis in internal medicine].
Malý J; Widimský J; Dulícek P
Vnitr Lek; 2009 Mar; 55(3):190-5. PubMed ID: 19378845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
